Skip to content

Delcath Systems DCTH Enterprise value

Enterprise value at other companies

Merit Medical Systems logo
Merit Medical SystemsMMSI
$4.43B-33.3%
Boston Scientific logo
Boston ScientificBSX
$141.04B-1.0%
Altimmune logo
AltimmuneALT
$337.85M+0.5%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$543.41M+96.3%
Wave Life Sciences logo
Wave Life SciencesWVE
$835.97M-18.1%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$5.33B+162%

Other financials

Income statement

See full
Revenue$25.0M+26.3%
Gross profit$21.3M+25.5%
Operating income-$1.6M-355%
Net income-$1.1M-200%
EPS (diluted)-$0.03-200%

Balance sheet

See full
Cash & equivalents$41.3M+223%
Total debt$907.0K-10.7%
Total equity$112.7M+40.5%
Total assets$124.8M+43.0%

Cash flow

See full
Operating cash flow$857.0K-61.1%
CapEx$570.0K+307%
Free cash flow$287.0K-86.1%

Valuation

See full
Market cap$425.31M-11.8%
P/E120.6×
P/S4.7×-4.3×

Profitability

See full
Gross margin86%+1.1pp
Operating margin-118.1%-56.8pp
Net margin1.5%+0.8pp
FCF margin21.2%+15.2pp

Returns & leverage

See full
Return on equity1.9%+1.0pp
Debt / equity0.0×
Current ratio11.2×-4.7×

Where this comes from

Calculated from Delcath Systems’s reported figures.

The official record: Delcath Systems’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Delcath Systems's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Delcath Systems's enterprise value?
Delcath Systems (DCTH) reported enterprise value of $282.05M in Q1 2026.
How has Delcath Systems's enterprise value changed year-over-year?
Delcath Systems's enterprise value decreased by 31.8% year-over-year, from $413.46M to $282.05M.
What is the long-term trend for Delcath Systems's enterprise value?
Over 5 years (2020 to 2025), Delcath Systems's enterprise value has grown at a 28.0% compound annual growth rate (CAGR), from $104.19M to $357.6M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.